Retinal thickness in Parkinson's disease

Area of Science:

• Ophthalmology
• Neuroscience
• Medical Imaging

Background:

• Parkinson's disease (PD) commonly causes visual symptoms, including reduced visual acuity and contrast sensitivity.
• Retinal thinning, detectable by optical coherence tomography (OCT), is a potential biomarker for neurodegeneration in PD.
• This study investigated retinal thickness in older PD patients using OCT.

Purpose of the Study:

• To assess the utility of optical coherence tomography (OCT) in measuring retinal thickness in an older cohort of Parkinson's disease (PD) patients.
• To compare retinal structure between PD patients and age-matched healthy controls.

Main Methods:

• Fifty-one PD patients and 25 healthy controls underwent ophthalmological assessment and OCT (Zeiss Stratus 3000™).
• Macular thickness, volume, and peripapillary retinal nerve fiber thickness were measured.
• Data exclusion criteria included co-morbid ocular pathology, poor OCT tolerability, or poor scan quality.

Main Results:

• Despite reduced visual acuity and contrast sensitivity in PD patients, no significant differences in retinal thickness were found between PD and control groups.
• This finding contrasts with some previous research suggesting retinal thinning in PD.

Conclusions:

• Technical challenges and the lack of observed differences indicate limitations of current OCT techniques for PD biomarker detection in this cohort.
• Longitudinal studies utilizing newer OCT technologies are necessary to clarify the role of OCT in diagnosing Parkinson's disease.